Find clinical trials for Triple Negative Breast Cancer in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Paris, Île-de-France, FRA:
This is a phase II study, preceded by a safety run-in, with two independent cohorts (cohort A in early Triple Negative Breast...
Phase 2
Paris, France and 1 other location
ISIdE is an European, multicentric study that aims to assess the efficacy of Sacituzumab Govitecan (SG) in locally advanced or metastatic triple...
Phase 3
Villejuif, France
Choice Of the Most Active Strategies for Short term recurring Triple Negative Breast Cancer:A phase Ib/II, open-l-...
Phase 1, Phase 2
Villejuif, France
Neoadjuvant treatment is an important part of the treatment strategy for locally advanced TNBC having established a positive and significant correlat...
Phase 1, Phase 2
Paris, France
This study aims to evaluate the efficacy and safety of preoperative Durvalumab in patients with early small (cT1N0) triple negative ...
Phase 2
Villejuif, France and 2 other locations
with unresectable locally advanced or metastatic PD-L1-positive Triple-Negative Breast Cancer (TNBC) who have not...
Phase 3
Levallois-Perret, France and 75 other locations
is an adenosine-generating enzyme overexpressed in several cancers and associated with poor prognosis and reduced anti-tumor...
Phase 1, Phase 2
Paris, France and 15 other locations
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Saint-Cloud, France and 199 other locations
for with primary objective to evaluate the efficacy of PLX038 on response rate for patients with pretreated, metastatic or locally advanced triple...
Phase 2
Paris, France and 1 other location
care, will benefit patients with previously untreated metastatic triple-negative breast cancer starting first-lin...
Paris, France and 50 other locations
Clinical trials
Research sites
Resources
Legal